Related Experiment Videos
[Ploidies of cardiomyocytes in human myocardial hypertrophy]
Insights
Adult heart hypertrophy involves a stable genome, not increased polyploidy in ventricular myocytes. However, congenital heart defects in children show significantly higher polyploidy levels in these cells.
Area of Science:
- Cardiology
- Molecular Biology
- Genetics
Background:
- Heart hypertrophy is a significant clinical condition.
- Understanding the cellular mechanisms of hypertrophy is crucial for effective treatment.
- Previous research has explored changes in cardiomyocyte DNA content during hypertrophy.
Purpose of the Study:
- To investigate DNA content and polyploidy in ventricular cardiomyocytes of human hearts with hypertrophy.
- To differentiate the mechanisms of hypertrophy in adults versus congenital heart defects.
- To test the hypothesis that adult hypertrophy involves a stable genome.
Main Methods:
- DNA cytophotometry was used to analyze DNA content in ventricular cardiomyocytes.
- Samples were obtained from adult hearts with hypertrophy due to atherosclerosis and post-infarct scars.
- Samples were also analyzed from hearts with hypertrophy caused by congenital heart defects.
Main Results:
- In adult hypertrophy (atherosclerosis, scars), polyploidy levels remained within normal childhood variability.
- Hypertrophy due to congenital heart defects showed significantly elevated polyploidy (mean level ≥20c), exceeding normal limits (approx. 10c).
- Adult heart hypertrophy occurs with a stable genome, not through increased myocyte polyploidization.
Conclusions:
- Adult heart hypertrophy is characterized by genome stability rather than redundant polyploidization of ventricular myocytes.
- Congenital heart defects are associated with enhanced polyploidization of myocytes during childhood.
- These findings suggest distinct cellular pathways for hypertrophy development based on etiology.
Abstract:
DNA cytophotometry has been performed in ventricular cardiomyocytes of hypertrophic human hearts. In the cases of hypertrophy in adults (generalized atherosclerosis, postinfarct scars), polyploidy expression did not exceed the limits of normal variability developed during childhood. In the cases of hypertrophy caused by congenital heart defects, high polyploidy has been revealed (the mean level 20c and more, where c is haploid DNA content), which considerably exceeded the upper limit of normal variability (approximately 10c). Our hypothesis has confirmed that heart hypertrophy in adults proceeds in conditions of stable genome rather than due to redundant polyploidization of the ventricular myocytes. The same idea assumes enhanced polyploidization of the myocytes in childhood in humans with congenital heart diseases.